Massimo Bernardi

个人简介

Massimo Bernardi医生是IRCCS圣拉斐尔科学研究医院血液病和骨髓移植科下属的血液病科(急性白血病和骨髓发育异常)负责人,在Fabio Ciceri教授的指导下开展工作。

1988年,Bernardi医生毕业于米兰大学医学院,1994年又在该校获得呼吸系统疾病专业学位,2000年获得血液学专业学位。

在临床工作中,Bernardi医生始终致力于为血液科中的血液病患者提供帮助。Bernardi医生重点关注急性髓系白血病和骨髓增生异常的患者,并为其提供一整套诊断和治疗方案。

他合作并参与了有关急性白血病和骨髓增生异常诊疗(尤其在老年人中)的自发研究和多中心研究。所述研究的目的在于确定预后指标,用于分析诊断决策以及疾病复发的预防和治疗。

目前,Bernardi医生在意大利国内外期刊上发表的文章(H指数为32)以及参与编写的大学教材(医学生和外科医生适用)章节共计112篇。

他也是意大利国内和国际上多个协会和工作组的成员:Francesco Lo Coco急性髓系白血病学会、欧洲血液学协会(EHA)、EMBT(欧洲血液及骨髓移植小组)慢性白血病工作组、EMBT急性白血病工作组、伦巴第血液学网络(REL)急性白血病委员会、REL骨髓增生异常委员会、MDS(骨髓增生异常综合征)基金会、致力于骨髓增生异常综合征的GITMO工作组(意大利骨髓移植工作组)。

教育背景

米兰大学
医学博士学位 - 1988年

米兰大学
呼吸系统疾病专业学位 - 1994年

米兰大学
血液学专业学位 - 2000年

您需要预约吗?

联系我们,我们将为您妥善安排。

出版物

最新出版物

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
J Clin Oncol. 2023;41(15):2827-2842. doi: 10.1200/JCO.22.01784
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao L, Caballero Berrocal JC, Sala C, Maggioni G, Bernardi M, Di Grazia C, Vago L, Rivoli G, Borin L, D'Amico S, Tentori CA, Ubezio M, Campagna A, Russo A, Mannina D, Lanino L, Chiusolo P, Giaccone L, Voso MT, Riva M, Oliva EN, Zampini M, Riva E, Nibourel O, Bicchieri M, Bolli N, Rambaldi A, Passamonti F, Savevski V, Santoro A, Germing U, Kordasti S, Santini V, Diez-Campelo M, Sanz G, Sole F, Kern W, Platzbecker U, Ades L, Fenaux P, Haferlach T, Castellani G, Della Porta MG
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
Nat Commun. 2023;14(1):1285. doi: 10.1038/s41467-023-36969-0
Naldini MM, Casirati G, Barcella M, Rancoita PMV, Cosentino A, Caserta C, Pavesi F, Zonari E, Desantis G, Gilioli D, Carrabba MG, Vago L, Bernardi M, Di Micco R, Di Serio C, Merelli I, Volpin M, Montini E, Ciceri F, Gentner B
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
Cancer. 2023;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. PMID: 36692409
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group
Imaging biomarkers of leukaemic choroidopathy
Acta Ophthalmol. 2023;101(5):553-559. doi: 10.1111/aos.15637
Menean M, Apuzzo A, Mastaglio S, Bernardi M, Ciceri F, Modorati G, Miserocchi E, Bandello F, Cicinelli MV
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB
Blood Adv. 2023;7(9):1621-1634. doi: 10.1182/bloodadvances.2022008226
Clerici D, Galli L, Greco R, Lugli AP, Erbella F, Ripa M, Tassan Din C, Nitti R, Giglio F, Mastaglio S, Lorentino F, Xue E, Farina F, Liberatore C, Poli A, Carletti S, Lupo Stanghellini MT, Carrabba MG, Assanelli AA, Ruggeri A, Bernardi M, Corti C, Peccatori J, Mancini N, Scarpellini P, Ciceri F, Castagna A, Oltolini C
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
Lancet Haematol 2022, Lancet Haematol. 2023;10(2): e117-e128.doi:10.1016/S2352-3026(22)00323-4
GenoMed4All consortium authors: Maggioni G, Bersanelli M, Travaglino E, Piérola A, Annika Kasprzak A, Sangerman Montserrat A, Sauta E, Sala C, Matteuzzi T, Meggendorfer M, Gnocchi M, Zhao L, Tentori CA , Nachtkamp K, Dall’Olio D, Mosca E, Ubezio M, Campagna A, Russo A, Rivoli G, Bernardi M, Borin L, Voso MT, Riva M, Oliva EN, Zampini M, Riva E, Saba E, D’Amico S, Lanino L, Tinterri B, Re F, Bicchieri M, Giordano L, Angelotti G, Morandini P, Kubasch AS, Passamonti F, Rambaldi A, Savevski V, Santoro A, Van de Loosdrecht AA, Brogi A, Santini V, Kordasti S, Sanz G, Sole F, Gattermann N, Kern W, Platzbecker U, Ades L, Fenaux P, Haferlach T, Castellani G, Germing U, Diez-Campelo M, Della Porta MG
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation
Haematologica. 2023 Jun 1;108(6):1530-1543. doi: 10.3324/haematol.2022.280685
Tassi E, Noviello M, De Simone P, Lupo-Stanghellini MT, Doglio M, Serio F, Abbati D, Beretta V, Valtolina V, Oliveira G, Racca S, Campodonico E, Ruggiero E, Clerici D, Giglio F, Lorentino F, Dvir R, Xue E, Farina F, Oltolini C, Manfredi F, Vago L, Corti C, Bernardi M, Clementi M, Brix L, Ciceri F, Peccatori J, Greco R, Bonini C
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
Cancers, 2022;14(12):3012. doi: 10.3390/cancers14123012
Messina M, Piciocchi A, Ottone T, Paolini S, Papayannidis C, Lessi F, Fracchiolla NS, Forghieri F, Candoni A, Mengarelli A, Martelli MP, Venditti A, Carella AM, Albano F, Mancini V, Bernardi M, Arena A, Sargentini V, Sciumè M, Pastore D, Todisco E, Roti G, Siragusa S, Ladetto M, Pravato S, De Bellis E, Simonetti G, Marconi G, Cerchione C, Fazi P, Vignetti M, Amadori S, Martinelli G, Voso MT
MRD in venetoclax-based treatment for AML: does it really matter?
Front Oncol 2022, Jul 18;12:890871. doi: 10.3389/fonc.2022.890871
Bernardi M, Ferrara F, Carrabba MG, Mastaglio S, Lorentino F, Vago L, Ciceri F
Retinal Microvascular Changes in Patients with Acute Leukemia
Retina. 2022;42(9):1762-1771. doi: 10.1097/IAE.0000000000003504
Cicinelli MV, Mastaglio S, Menean M, Marchese A, Miserocchi E, Modorati G, Bernardi M, Ciceri F, Bandello F
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience
Bone Marrow Transplant. 2022; 57:678–680; https://doi.org/10.1038/s41409-022-01600-1
Piemontese S, Lazzari L, Ruggeri A, Marcatti M, Lupo Stanghellini MT, Giglio F, Greco R, Lorentino F, Clerici D, Assanelli A, Farina F, Mastaglio S, Xue E, Marktel S, Vago L, Gentner B, Secco C, Corti C, Carrabba MG, Bernardi M, Peccatori J, Ciceri F
Drug treatment options for acute promyelocytic leukemia
Expert Opin Pharmacother. 2022;23(1):117-127. doi: 10.1080/14656566.2021.1961744
Ferrara F, Molica M, Bernardi M
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia
Nature Communications 2021; 12(1):4844. doi: 10.1038/s41467-021-25223-0.
Consonni M, Garavaglia C, Grilli A, de Lalla C, Mancino A, Mori L, De Libero G, Montagna D, Casucci M, Serafini M, Bonini C, Häussinger D, Ciceri F, Bernardi M, Mastaglio S, Bicciato S, Dellabona P, Casorati G

您需要预约吗?

联系我们,我们将为您妥善安排。